COMAR, INC. – Trademark Portfolio
Entity Type: 03
COMAR, INC. owns a portfolio of 25 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as C, COD, COMAR, PLATE+, and ACCUCUP. Of these, 11 are registered. The portfolio spans 7 Nice Classification classes, led by Class 9 (Computers & Electronics) and Class 10 (Medical Apparatus). Headquartered in BUENA, NJ.
ONE COMAR PLACE
BUENA, NJ 08310
Showing of trademarks Trademarks
Trademark Classifications
COMAR, INC.'s trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does COMAR, INC. have?
COMAR, INC. has 25 U.S. trademarks filed with the USPTO. Of these, 11 registered, 6 abandoned, 8 cancelled.
What trademark classes does COMAR, INC. file in?
COMAR, INC. files trademarks across 7 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 20 (Furniture), Class 35 (Advertising & Business), Class 40 (Treatment & Processing). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are COMAR, INC.'s most well-known trademarks?
COMAR, INC.'s registered trademark portfolio includes well-known marks such as C, COD, COMAR, PLATE+, and ACCUCUP. These are among 11 currently registered trademarks in the portfolio.
What is COMAR, INC.'s trademark registration success rate?
COMAR, INC. has a 44% trademark registration rate, with 11 out of 25 resolved applications resulting in successful registration. Currently, 0 applications are pending review.